Fabrication and Characterization of Azithromycin-Loaded Niosomes for Periodontitis Treatment

Article Preview

Abstract:

Azithromycin (AZM) is a potential drug for periodontitis treatment, but its poor water solubility could be problematic for local delivery to periodontal tissues. Entrapping AZM, which is a hydrophobic drug into niosomes, could effectively deliver drugs to the target site. This study aimed to design and fabricate azithromycin-loaded niosomes (NAZ) with desirable properties for intra-periodontal pocket administration. Span 60 and cholesterol were used to prepare niosomes with modified reverse phase evaporation method. NAZ were characterized and the effects of niosome composition were investigated. In vitro release and cell viability were evaluated. The results of this study indicated that with the specific ratio of Span 60 and cholesterol, the particle sizes of niosomes were in nano-sized (319 nm) with optimal zeta potential (-39.57 mV). Controlled release of AZM was achieved with release kinetic followed zero order model. NAZ exhibited low toxicity as cell viability was comparable to negative control.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

55-60

Citation:

Online since:

October 2021

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2021 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] J. Meyle, I. Chapple, Molecular aspects of the pathogenesis of periodontitis, Periodontol. 2000. 69 (2015) 7–17.

DOI: 10.1111/prd.12104

Google Scholar

[2] F.A. Carranza, P.M. Camargo, The periodontal pocket, in: M.G. Newman, H.H. Takei, P.R. Klokkevold, F.A. Carranza, Carranza's Clinical Periodontology, 12th edition, Elsevier Saunders, 2015, pp.277-289.

DOI: 10.1016/b978-1-4377-0416-7.00110-4

Google Scholar

[3] K. Jepsen, S. Jepsen, Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis, Periodontol. 2000. 71 (2016) 82–112.

DOI: 10.1111/prd.12121

Google Scholar

[4] R. Hirsch, H. Deng, M.N. Laohachai, Azithromycin in periodontal treatment: more than an antibiotic, J. Periodontal Res. 47 (2012) 137–148.

DOI: 10.1111/j.1600-0765.2011.01418.x

Google Scholar

[5] N. M. Idkaidek, N. Najib, I. Salem, J. Jilani, Physiologically-Based IVIVC of Azithromycin, Am. J. Pharmacol. Sci. 2 (2014) 100–102.

DOI: 10.12691/ajps-2-6-1

Google Scholar

[6] S. Limsitthichaikoon, B. Khampaenjiraroch, T. Damrongrungruang, W. Limphirat, S. Thapphasaraphong, A. Priprem, Topical oral wound healing potential of anthocyanin complex: animal and clinical studies, Ther. Deliv. 9 (2018) 359–374.

DOI: 10.4155/tde-2017-0123

Google Scholar

[7] F.J. Szoka, D. Papahadjopoulos, Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation, Proc. Natl. Acad. Sci. USA. 75 (1978) 4194-4198.

DOI: 10.1073/pnas.75.9.4194

Google Scholar

[8] J. Jiang, G. Oberdörster, P. Biswas, Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies, J. Nanoparticle Res. 11 (2009) 77–89.

DOI: 10.1007/s11051-008-9446-4

Google Scholar

[9] T. Watanabe, W. Soeda, K. Kobayashi, M. Nagao, The pH value changes in the periodontal pockets, Bull. TOKYO Med. Dent. Univ. 43 (1996) 67–73.

Google Scholar

[10] D. Kaushik, P. Kumar, S. Sardana, Design Development and Evaluation of Nanosuspension of Azithromycin, Int. J. Pharm. Sci. Drug Res. (2015) 384–394.

Google Scholar

[11] P.-C. Lai, W. Ho, N. Jain, J.D. Walters, Azithromycin Concentrations in Blood and Gingival Crevicular Fluid After Systemic Administration, J. Periodontol. 82 (2011) 1582–1586.

DOI: 10.1902/jop.2011.110012

Google Scholar

[12] S. Limsitthichaikoon, A. Priprem, T. Damrongrungruang, Niosomes Encapsulated Anthocyanins Complex Loaded in a Topical Oral Gel, Key Eng. Mater. 859 (2020) 232–238.

DOI: 10.4028/www.scientific.net/kem.859.232

Google Scholar

[13] S. Dash, P.N. Murthy, L. Nath, P. Chowdhury, Kinetic modeling on drug release from controlled drug delivery systems, Acta Pol. Pharm. 67 (2010) 217–223.

Google Scholar